Ceftazidime-Avibactam Use in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections

Clinical trial NCT05258851 · TERMINATED

Trial details

NCT number: NCT05258851
Sponsor: King Faisal Specialist Hospital & Research Center
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Carbapenem-Resistant Enterobacteriaceae Infection

Start date: 2022-06-01
Primary completion: 2023-04-12
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.